PARI Pharma GmbH - Product Pipeline Review - 2013 - New Market Research Report

Global Market Direct's pharmaceuticals report, "PARI Pharma GmbH - Product Pipeline Review - 2013" provides data on the PARI Pharma GmbH's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, PARI Pharma GmbH's corporate website, SEC filings, investor presentations and featured press releases, both from PARI Pharma GmbH and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- http://www.fastmr.com/prod/647177_pari_pharma_gmbh_product_pipeline_review_2013.aspx?afid=301

Scope

* PARI Pharma GmbH - Brief PARI Pharma GmbH overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of PARI Pharma GmbH human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of PARI Pharma GmbH with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the PARI Pharma GmbH's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Evaluate PARI Pharma GmbH's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of PARI Pharma GmbH in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the PARI Pharma GmbH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with PARI Pharma GmbH.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of PARI Pharma GmbH and identify potential opportunities in those areas.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- PARI Pharma GmbH - Product Pipeline Review - 2012
- Grunenthal GmbH - Product Pipeline Review - 2013
- Dr. Falk Pharma GmbH - Product Pipeline Review - 2012
- Merz Pharma GmbH & Co. KgaA - Product Pipeline Review - 2012
- Isis Pharmaceuticals, Inc. - Product Pipeline Review - 2013